Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR
Vanguard Capital Management LLC reported a 5.05% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Capital Management LLC reported a 5.05% stake in Arrowhead Pharmaceuticals, Inc., 7,081,293 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.05%
- Shares
- 7,081,293
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.05% | 7,081,293 |
Source
Related
- Arrowhead Pharmaceuticals, Inc.
- Vanguard Capital Management LLC
- Arrowhead Pharmaceuticals, Inc. shareholders
- Form 4 · Olukotun Adeoye Y · Aug 20, 2026
- Form 4 · Perry Michael S · Aug 20, 2026
- Schedule 13G/A · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026